#United States #Philadelphia #Pediatric Research #brain tumors #Children’s Brain Tumor Network

CBTN Launches Updated Branding

On February 2, 2026, the Children's Brain Tumor Network (CBTN) introduced a new branding initiative that encapsulates its role as a leading global research community aimed at improving the outcomes for children with brain tumors. The revamp is not just cosmetic; it reflects the organization's evolution into a sophisticated platform driving innovation through data-driven discovery.

Since its inception in 2011, CBTN has been at the forefront of uniting various stakeholders, including researchers, clinical experts, families, and philanthropic foundations. Their collaborative approach has transformed pediatric brain tumor research, combining cutting-edge technology and a culture of openness in science that allows for real-time cooperation among institutions.

Adam Resnick, PhD, Co-Executive Director at the Center for Data-Driven Discovery in Biomedicine at Children’s Hospital of Philadelphia, expressed the necessity for this update. "CBTN has matured into a global, cloud-enabled research engine, fueled by partners that are reshaping pediatric brain tumor science. This moment allows us to reflect the sophistication of our ecosystem and the breakthroughs we are facilitating," stated Resnick.

Enhancing Communication and Engagement

The brand upgrade involves a new visual identity, streamlined messaging, and improved digital platforms. These enhancements aim to provide better access to vital data and resources while fostering collaboration throughout the international network. Wendy Payton, Director of Communications for CBTN, emphasized that clarity is essential in promoting their mission. "Our organization has always fostered discovery through connection. With these updates, we can convey our strength with precision, aiding partners in joining our mission," Payton noted.

United We Cure

Central to the aesthetic and messaging shift is the tagline "United We Cure." This phrase symbolizes CBTN's commitment to collaborative scientific advancement. It positions the organization as a facilitator that merges people, data, and shared aspirations to hasten the development of effective treatments for children suffering from brain tumors.

As a global research community, CBTN maintains an extensive collection of harmonized clinical and genomic data, biospecimens, preclinical models, and imaging resources. This data is made available through cloud-based platforms that enhance real-time collaboration across diverse institutional landscapes.

By fostering a transparent and inclusive atmosphere, CBTN not only encourages but accelerates discoveries that could lead to substantial improvements in patient care and treatment outcomes. The revamped branding reflects their commitment to this ambitious aim.

In conclusion, this new branding initiative is not only a change of appearance but a revitalization of purpose. It marks a fresh chapter in CBTN's ongoing journey to advance pediatric brain tumor research and underscores its ongoing dedication to enhancing the lives of affected children and their families. For more information, visitors can explore their website at CBTN.org.